JP2023532128A5 - - Google Patents
Info
- Publication number
- JP2023532128A5 JP2023532128A5 JP2022581398A JP2022581398A JP2023532128A5 JP 2023532128 A5 JP2023532128 A5 JP 2023532128A5 JP 2022581398 A JP2022581398 A JP 2022581398A JP 2022581398 A JP2022581398 A JP 2022581398A JP 2023532128 A5 JP2023532128 A5 JP 2023532128A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- pharmaceutical composition
- alkyl
- composition according
- alkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063047612P | 2020-07-02 | 2020-07-02 | |
| US63/047,612 | 2020-07-02 | ||
| PCT/US2021/040171 WO2022006447A1 (en) | 2020-07-02 | 2021-07-01 | Compounds having anticancer activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023532128A JP2023532128A (ja) | 2023-07-26 |
| JP2023532128A5 true JP2023532128A5 (https=) | 2024-07-09 |
Family
ID=79314944
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023524493A Pending JP2023535527A (ja) | 2020-07-02 | 2021-07-01 | 抗菌活性を有する化合物 |
| JP2022581398A Pending JP2023532128A (ja) | 2020-07-02 | 2021-07-01 | 抗がん作用を有する化合物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023524493A Pending JP2023535527A (ja) | 2020-07-02 | 2021-07-01 | 抗菌活性を有する化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20230295164A1 (https=) |
| EP (2) | EP4175953A4 (https=) |
| JP (2) | JP2023535527A (https=) |
| CN (2) | CN115867354B (https=) |
| AU (2) | AU2021299504A1 (https=) |
| CA (2) | CA3183770A1 (https=) |
| WO (2) | WO2022006432A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11963959B2 (en) * | 2021-08-17 | 2024-04-23 | Southwest Research Institute | Inhibitors for coronavirus |
| WO2024077235A2 (en) * | 2022-10-07 | 2024-04-11 | The Trustees Of Princeton University | Dihydrofolate reductase inhibitors for anti-biotic resistant infections |
| CN118047780A (zh) * | 2022-11-09 | 2024-05-17 | 中国医学科学院药物研究所 | 一类喹唑啉杂环化合物及其抗感染和抗肿瘤的应用 |
| CN119661535B (zh) * | 2023-09-21 | 2026-03-20 | 中国医学科学院药物研究所 | 7H-吡咯并[3,2-f]喹唑啉衍生物及其抗感染应用 |
| WO2025194625A1 (zh) * | 2024-03-22 | 2025-09-25 | 深圳湾实验室坪山生物医药研发转化中心 | 结核病的预防与治疗 |
| WO2025195460A1 (zh) * | 2024-03-22 | 2025-09-25 | 深圳湾实验室坪山生物医药研发转化中心 | 稠环衍生物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE45427B1 (en) * | 1976-07-09 | 1982-08-25 | American Home Prod | Pyrrold 3,2if quinazoline-1,3-diamine and related compounds |
| US4118561A (en) * | 1977-04-06 | 1978-10-03 | American Home Products Corporation | 7-(Substituted)-7H-pyrrolo[3,2-f]quinazoline-1,3-diamines |
| JP2005500253A (ja) * | 2001-02-23 | 2005-01-06 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | トロンビン受容体アンタゴニストとしてのアミノメチルピロロキナゾリン化合物 |
| US7253177B2 (en) * | 2004-10-22 | 2007-08-07 | United States Of America As Represented By The Secretary Of The Army | Synthesis and antimalarial activity of pyrrolo[3,2-f]quinazoline-1,3-diamine derivatives |
| US9920058B2 (en) * | 2013-05-06 | 2018-03-20 | Georgia Tech Research Corporation | Molecules with potent DHFR binding affinity and antibacterial activity |
| EP3010923A4 (en) * | 2013-06-20 | 2016-12-14 | Univ Oregon Health & Science | PYRROLOCHINAZOLINVERBINDUNGEN |
| WO2015173802A1 (en) * | 2014-05-11 | 2015-11-19 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Par-1 based therapeutic conjugates and uses thereof |
| US11077109B2 (en) * | 2017-08-01 | 2021-08-03 | The Trustees Of Princeton University | Compounds having antibacterial activity and methods of use |
| US20210161900A1 (en) * | 2018-04-30 | 2021-06-03 | Duke University | Compositions and methods for the treatment of senescent tumor cells |
| CN114514230A (zh) * | 2019-08-20 | 2022-05-17 | 希望之城 | Mettl16抑制剂及其用途 |
-
2021
- 2021-07-01 AU AU2021299504A patent/AU2021299504A1/en active Pending
- 2021-07-01 AU AU2021301264A patent/AU2021301264A1/en active Pending
- 2021-07-01 CA CA3183770A patent/CA3183770A1/en active Pending
- 2021-07-01 JP JP2023524493A patent/JP2023535527A/ja active Pending
- 2021-07-01 EP EP21832744.3A patent/EP4175953A4/en active Pending
- 2021-07-01 US US18/014,032 patent/US20230295164A1/en active Pending
- 2021-07-01 CN CN202180047260.2A patent/CN115867354B/zh active Active
- 2021-07-01 CA CA3183776A patent/CA3183776A1/en active Pending
- 2021-07-01 WO PCT/US2021/040143 patent/WO2022006432A1/en not_active Ceased
- 2021-07-01 CN CN202180047426.0A patent/CN116234808B/zh active Active
- 2021-07-01 US US18/013,302 patent/US20230242540A1/en active Pending
- 2021-07-01 WO PCT/US2021/040171 patent/WO2022006447A1/en not_active Ceased
- 2021-07-01 EP EP21832527.2A patent/EP4175958A4/en active Pending
- 2021-07-01 JP JP2022581398A patent/JP2023532128A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023532128A5 (https=) | ||
| JP2021523221A5 (https=) | ||
| RU2350605C2 (ru) | Аналоги хиназолина в качестве ингибиторов рецепторных тирозинкиназ | |
| RU2481346C2 (ru) | Ингибиторы фосфатидилинозитол-3-киназы | |
| JP2012508252A5 (https=) | ||
| JP2021534124A5 (https=) | ||
| JP2021516231A5 (https=) | ||
| RU2004111979A (ru) | Производные 1н-имидазола, обладающие св1-агонистической, частичной св1-агонистической или св1-антагонистической активностью | |
| RU2012116584A (ru) | Лизинспецифические ингибиторы деметилазы-1 и их применение | |
| RU2014115847A (ru) | Пирролопиримидиновые соединения для лечения злокачественной опухоли | |
| RU2015118647A (ru) | Аминопиримидиновые соединения в качестве ингибиторов содержащих т790м мутантных egfr | |
| JP2015520143A5 (https=) | ||
| JP2011509309A5 (https=) | ||
| JP2017528498A5 (https=) | ||
| JP2015517574A5 (https=) | ||
| CA2474192A1 (en) | Nicotinamide derivates useful as p38 inhibitors | |
| AR038914A1 (es) | Indazoles substituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion para fabricar un medicamento | |
| JP2011526913A5 (ja) | キナゾリン化合物及び同化合物を含む治療薬 | |
| JP2021524482A5 (https=) | ||
| RU2013112871A (ru) | Соединения для лечения рака | |
| JP2023504542A5 (https=) | ||
| JP2023538524A5 (https=) | ||
| JP2020502116A5 (https=) | ||
| CA2479363A1 (en) | Thiopyrimidine and isothiazolopyrimidine kinase inhibitors | |
| JP2006520761A5 (https=) |